Literature DB >> 11404288

Role of ET(A) receptors in experimental ANG II-induced hypertension in rats.

J R Ballew1, G D Fink.   

Abstract

The objectives were to determine if ANG II-induced hypertension is maintained by activation of endothelin type A (ET(A)) receptors by endogenous ET-1 and if this effect is influenced by salt intake. Male rats were maintained on high sodium intake (HS; 6 meq/day) or on normal sodium intake (NS; 2 meq/day). Hypertension was produced by intravenous infusion of ANG II (5 ng/min) for 15 days. Five-day oral dosing with the selective ET(A)-receptor antagonist ABT-627 (~2 mg. kg(-1). day(-1)) reduced mean arterial pressure (MAP) to baseline levels in rats on HS receiving ANG II infusion, but it did not affect MAP in normotensive HS controls. In rats on NS, ABT-627 only transiently decreased MAP in rats receiving ANG II and slightly reduced MAP in normotensive controls. ABT-627 produced mild retention of sodium and water in NS rats receiving ANG II, but not in any other group. These results indicate that ET-1 plays a role in ANG II-induced hypertension via activation of ET(A) receptors and that this role is more prominent in rats on HS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404288     DOI: 10.1152/ajpregu.2001.281.1.R150

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  11 in total

1.  Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet.

Authors:  Erika I Boesen; Jennifer S Pollock; David M Pollock
Journal:  Can J Physiol Pharmacol       Date:  2010-08       Impact factor: 2.273

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 4.  2013 Dahl Lecture: American Heart Association council for high blood pressure research clarifying the physiology of endothelin.

Authors:  David M Pollock
Journal:  Hypertension       Date:  2014-03-10       Impact factor: 10.190

Review 5.  Endothelin, the kidney, and hypertension.

Authors:  Joey P Granger; Sean Abram; David Stec; Derrick Chandler; Babbette LaMarca
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 6.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

7.  ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.

Authors:  Erika I Boesen; Karthik R Krishnan; Jennifer S Pollock; David M Pollock
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

8.  Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.

Authors:  Li Yao; Hiroyuki Kobori; Matlubur Rahman; Dale M Seth; Takatomi Shokoji; Yuyan Fan; Guo-Xing Zhang; Shoji Kimura; Youichi Abe; Akira Nishiyama
Journal:  Hypertens Res       Date:  2004-07       Impact factor: 3.872

9.  Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

Authors:  T Kobayashi; T Nogami; K Taguchi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

10.  Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt-induced renal injury and inflammation.

Authors:  Carmen De Miguel; Randee Sedaka; Malgorzata Kasztan; Jeremie M Lever; Michelle Sonnenberger; Andrew Abad; Chunhua Jin; Pamela K Carmines; David M Pollock; Jennifer S Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-12-23       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.